Test Price
2,800 AED✅ Home Collection Available
KCTD17 Gene DYT26 Myoclonic Dystonia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل KCTD17 الجيني لخلل التوتر العضلي الرمعي DYT26 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Hospital-Grade Home Collection via ISO-Certified Cold-Chain Phlebotomy and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance to interpret results within your clinical context.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
الملخص التنفيذي: تحليل تسلسل الجين KCTD17 بتقنية الجيل التالي لتشخيص خلل التوتر العضلي الرمعي الوراثي (DYT26) بدقة تشخيصية تصل إلى 99.9%. خدمة جمع العينات المنزلية معتمدة ومطابقة لمعيار ISO 9001:2015. يقدم مركزنا استشارة ما بعد الفحص عبر الهاتف لتفسير النتائج. السعر 2800 درهم. يمكن التحقق من تغطية التأمين عبر واتساب.
Overview of the KCTD17 Genetic Test
The KCTD17 gene encodes a potassium channel tetramerization domain-containing protein; mutations cause autosomal dominant myoclonic dystonia (DYT26) characterized by lightning-like myoclonus and cervical dystonia. This NGS-based genetic test sequences all coding exons and splice junctions to detect pathogenic variants, enabling definitive molecular diagnosis and tailored management.
يحدد تحليل الجين KCTD17 الطفرات المسببة لخلل التوتر العضلي الرمعي (DYT26) بواسطة التسلسل الجيني المتقدم.
| Parameter | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% sensitivity for all variant types, including deep intronic | >99% for targeted exons; may miss rare large deletions |
| Method | Next Generation Sequencing (Illumina platform) with CNV analysis | Bidirectional Sanger sequencing of coding regions only |
| Speed (TAT) | 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocol
“Genetic diagnosis of myoclonic dystonia is a sensitive step that must be correlated with clinical findings and family history. A positive result does not predict disease severity, while a negative result does not exclude other genetic causes. I always advise my patients to involve a neurologist before making any treatment decisions.” — Dr. PRABHAKAR REDDY, DHA License No. 61713011
Medication Warning:
Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic purposes only and should not replace ongoing clinical care.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent or with unconfirmed clinical indication.
- Exclusion (Minors): Genetic testing in minors requires explicit parental consent in line with UAE CDS Law 2026; an ethics consultation may be mandated.
- Exclusion: Inability to provide a viable blood or DNA sample after two attempts.
- ER Red Flags: Sudden onset of severe dystonic storm, status dystonicus, respiratory compromise, or myoclonus with loss of consciousness — seek immediate emergency care. For neurological emergencies, call 998 or proceed to the nearest ER.
Patient FAQ & Clinical Guidance
1. What is the KCTD17 gene test and who needs it?
Snippet: KCTD17 gene test diagnoses hereditary myoclonic dystonia DYT26 by sequencing the entire coding region via NGS. It is indicated for patients with unexplained myoclonus and dystonia, at-risk family members, and for prenatal diagnosis when a known familial mutation exists. A pre-test genetic counseling session is mandatory.
2. How is the sample collected and is it painful?
Snippet: Home blood draw via cold-chain phlebotomy or a simple finger-prick DNA FTA card ensures non-invasive sample collection. Our trained phlebotomists use pediatric-friendly techniques; the procedure is similar to a routine blood test and causes minimal discomfort.
3. How long until I receive results and will someone explain them?
Snippet: Results are delivered in 3–4 weeks with complimentary post- telephone clinical guidance by a neurologist or genetic counselor. We provide a detailed report of any pathogenic variant, its clinical significance, and recommended follow-up. For Arabic-speaking patients, a bilingual report summary is available.
بالعربية: تظهر نتائج التحليل خلال 3 إلى 4 أسابيع مع استشارة هاتفية مجانية لتفسير النتائج من قبل طبيب أعصاب أو مستشار وراثي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians